| Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy HG Wendel, E Stanchina, JS Fridman, A Malina, S Ray, S Kogan, ... Nature 428 (6980), 332-337, 2004 | 1204 | 2004 |
| Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia BD Santomasso, JH Park, D Salloum, I Riviere, J Flynn, E Mead, E Halton, ... Cancer discovery 8 (8), 958-971, 2018 | 702 | 2018 |
| RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer AL Wolfe, K Singh, Y Zhong, P Drewe, VK Rajasekhar, VR Sanghvi, ... Nature 513 (7516), 65-70, 2014 | 630 | 2014 |
| Dissecting eIF4E action in tumorigenesis HG Wendel, RLA Silva, A Malina, JR Mills, H Zhu, T Ueda, ... Genes & development 21 (24), 3232-3237, 2007 | 574 | 2007 |
| The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development A Ortega-Molina, IW Boss, A Canela, H Pan, Y Jiang, C Zhao, M Jiang, ... Nature medicine 21 (10), 1199-1208, 2015 | 422 | 2015 |
| Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia KJ Mavrakis, AL Wolfe, E Oricchio, T Palomero, K De Keersmaecker, ... Nature cell biology 12 (4), 372-379, 2010 | 416 | 2010 |
| Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model ME Bordeleau, F Robert, B Gerard, L Lindqvist, SMH Chen, HG Wendel, ... The Journal of clinical investigation 118 (7), 2651-2660, 2008 | 380 | 2008 |
| A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL) KJ Mavrakis, J Van Der Meulen, AL Wolfe, X Liu, E Mets, T Taghon, ... Nature genetics 43 (7), 673-678, 2011 | 327 | 2011 |
| A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL) KJ Mavrakis, J Van Der Meulen, AL Wolfe, X Liu, E Mets, T Taghon, ... Nature genetics 43 (7), 673-678, 2011 | 322 | 2011 |
| mTORC1 promotes survival through translational control of Mcl-1 JR Mills, Y Hippo, F Robert, SMH Chen, A Malina, CJ Lin, U Trojahn, ... Proceedings of the National Academy of Sciences 105 (31), 10853-10858, 2008 | 313 | 2008 |
| GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells EL Smith, K Harrington, M Staehr, R Masakayan, J Jones, TJ Long, KY Ng, ... Science translational medicine 11 (485), eaau7746, 2019 | 277 | 2019 |
| CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas Y Jiang, A Ortega-Molina, H Geng, HY Ying, K Hatzi, S Parsa, D McNally, ... Cancer discovery 7 (1), 38-53, 2017 | 257 | 2017 |
| Loss of the HVEM tumor suppressor in lymphoma and restoration by modified CAR-T cells M Boice, D Salloum, F Mourcin, V Sanghvi, R Amin, E Oricchio, M Jiang, ... Cell 167 (2), 405-418. e13, 2016 | 256 | 2016 |
| The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma E Oricchio, G Nanjangud, AL Wolfe, JH Schatz, KJ Mavrakis, M Jiang, ... Cell 147 (3), 554-564, 2011 | 220 | 2011 |
| The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia J Van der Meulen, V Sanghvi, K Mavrakis, K Durinck, F Fang, ... Blood, The Journal of the American Society of Hematology 125 (1), 13-21, 2015 | 203 | 2015 |
| Small cell lung cancer: can recent advances in biology and molecular biology be translated into improved outcomes? PA Bunn Jr, JD Minna, A Augustyn, AF Gazdar, Y Ouadah, MA Krasnow, ... Journal of Thoracic Oncology 11 (4), 453-474, 2016 | 200 | 2016 |
| Loss of p53 impedes the antileukemic response to BCR-ABL inhibition HG Wendel, E de Stanchina, E Cepero, S Ray, M Emig, JS Fridman, ... Proceedings of the National Academy of Sciences 103 (19), 7444-7449, 2006 | 168 | 2006 |
| Loss of p53 impedes the antileukemic response to BCR-ABL inhibition HG Wendel, E de Stanchina, E Cepero, S Ray, M Emig, JS Fridman, ... Proceedings of the National Academy of Sciences 103 (19), 7444-7449, 2006 | 168 | 2006 |
| RiboDiff: detecting changes of mRNA translation efficiency from ribosome footprints Y Zhong, T Karaletsos, P Drewe, VT Sreedharan, D Kuo, K Singh, ... Bioinformatics 33 (1), 139-141, 2017 | 153 | 2017 |
| Endogenous expression of HrasG12V induces developmental defects and neoplasms with copy number imbalances of the oncogene X Chen, N Mitsutake, K LaPerle, N Akeno, P Zanzonico, VA Longo, ... Proceedings of the National Academy of Sciences 106 (19), 7979-7984, 2009 | 149 | 2009 |
